News

The Manila Times13d
OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab
"We also observed an increase in symptomatic remission rates across groups in the OLE, with the 850 mg induction phase dose ...
Nigerian Tribune on MSN19h
Abducted Ondo APC chair killed after N5m ransom payment
The Chairman of the All Progressives Congress (APC) in Ifon, Ondo State, Nelson Adepoyigi, who was abducted by gunmen while ...
Morningstar13d
OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab
NANTES, France – May 5, 2025, 6:30 p.m. CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announced that over >90% of people living with ulcerative colitis (UC) who achieved a ...